Summary
Using the number of calls to the Canadian Motherisk Program as an indicator of the drugs and chemicals frequently of concern to mothers during pregnancy, the risks to the fetus of exposure to these compounds have been reviewed.
The drugs which were of concern, and have been proven to be teratogenic, included alcohol, alkylating and antimetabolite agents, stilboestrol, disulfiram, heparin, lithium carbonate, phenytoin, tretinoin (retinoic acid), troxidone and valproic acid. For other compounds studied, there was either no data in the literature or no clear evidence of teratogenicity. The combination of doxylamine and pyridoxine, for example, has been associated with limb reduction defects in isolated case reports: cohort and case-control studies have failed to show a higher-than-baseline risk of malformations. In some cases of exposure to compounds with no known teratogenic potential, other adverse effects to the fetus are possible, and these effects are discussed in detail. In conclusion, when advising a pregnant woman about the potential teratogenic effect of a particular drug or chemical exposure, the health professional should also discuss other factors such as age, obstetric and medical history and the history of other exposures (including alcohol and smoking). In every pregnancy there is a 1 to 5% risk of mayor malformations, and even if the exposure does not appear to increase the teratogenic risk, such a risk still exists.
Similar content being viewed by others
References
Aldridge JFL. Visual display units and health. Practitioner 229: 539–545, 1985
Archer KA, Poland BJ. An embryo with developmental abnormalities in association with multiple maternal factors. Teratology 11: 13A, 1975
Bellinger D, Leviton A, Watermaux C, Needleman H, Rabinowitz M. Longitudinal analysis of prenatal and postnatal lead exposure and early cognitive development. New England Journal of Medicine 316: 1037–1043, 1987
Berkowitz RL, Constan DR, Mochizuki TK. Handbook for prescribing medications during pregnancy, Little, Brown and Company, Boston, 1981
Bracken MB, Holford TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstetrics and Gynecology 58: 336–344, 1981
Brent RL, Beckman DA. Clinics in Dermatology, Vol. 13, No. 3, WB Saunders, Philadelphia, 1986
Briggs GC, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 2nd ed., Williams and Williams, Baltimore, 1986
Brogden RN, Speight TM, Avery GS. Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 15: 93–131, 1978
Brumfitt W, Prusell R. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. British Medical Journal 2: 673–676, 1972
Burnett C, Goldenthal EI, Harris SB, Wazeter FX, Strausburg J, et al. Teratology and percutaneous toxicity studies on hair dyes. Journal of Toxicology and Environmental Health 1: 1027–1040, 1976
Cantu JM, Garcia-Cruz D. Midline facial defect as a teratogenic effect of metronidazole. Birth Defects 18: 85–88, 1982
Ceccarelli P, Rossi M, Cianti F, Domenici C. Use of amoxicillin in the obstetrical and gynecological field. Minerva Ginecologica 29: 137–142, 1977
Char VC, Chandra R, Fletcher AB, Avery GB. Polyhydramnios and neonatal renal failure: a possible association with maternal acetaminophen ingestion. Journal of Pediatrics 86: 638–639, 1975
Chaube S, Murphy ML. The teratogenic effects of 5-fluorocytosine in the rat. Cancer Research 29: 554–557, 1969
Chu Chen K, Sabeti S. L’evaluation clinique de la cephalexin orale. International Journal of Clinical Pharmacology 2 (Suppl.): 124–128, 1970
Cipriani S, Conti R, Vella G. Ranitidine in pregnancy: three case reports. Clinica Europea 22 (1): 1983
Close LG, Catlin FI, Cohn AM. Acute and chronic effects of ammonia burns of the respiratory tract. Archives of Otolaryngology 106: 151–158, 1980
Cohlan SQ. Tetracycline staining of teeth. Teratology 15: 127–130, 1977
Collins E, Turner G. Maternal effects of regular salicylate ingestion in pregnancy. Lancet 2: 335–337, 1975
Colombo ML, Dogliani P. Rubella embryopathy caused by vaccination: a clinical case with unusual characteristics. Minerva Pediatrica 28: 2429–2436, 1976
Corby DG. Aspirin and pregnancy: maternal and fetal effects. Pediatrics 62 (Suppl): 930–937, 1978
Corcoran R, Castles JM. Tetracycline for acne vulgaris and possible teratogenesis. British Medical Journal 2: 807–808, 1977
Courtney KD, Andrews JE, Springer J, Dalley L. Teratogenic evaluation of the pesticides baygon, carbofuran, dimethoate, and EPN. Journal of Environmental Science and Health B20(4): 373–406, 1985
Crawford JS. Cimetidine in elective caesarian section. Anaesthesia 36: 641–642, 1981
Crawford JS, Lewis M. Nitrous oxide in early human pregnancy. Anaesthesia 41: 900–905, 1986
Culshaw JA. TTC and congenital limb abnormalities. British Medical Journal 2: 924, 1962
Czeizel A. Diazepam, phenytoin and etiology of cleft lip and/or cleft palate. Lancet 1: 810, 1976
DiNardo JC, Picciano JC, Schnetzinger RW, Morris WE, Wolf BA. Teratological assessment of five oxidative hair dyes in the rat. Toxicology and Applied Pharmacology 78: 163–166, 1985
Diro M, Beydoun SN. Malaria in pregnancy. Southern Medical Journal 75: 959–962, 1982
Dobbins PK. Organic phosphate insecticides as teratogens in the rat. Journal of the Florida Medical Association 54: 452–456, 1967
Editorial. Is there a fetal solvent syndrome? Reproductive Toxicology 2 (5): 1983
Elder HA, Santamarina BAG, Smith S, Kass EH. The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy. American Journal of Obstetrics and Gynecology 111: 441–462, 1971
Fabro S, Scialli AR. Drug and chemical action in pregnancy, Marcel Dekker, Inc., New York, 1986
Fahim MS, Fahim Z, Hall DG. Effects of subtoxic lead levels on pregnant women in the state of Missouri. International Conference on Heavy Metals in the Environment, Toronto, 1975
Frohberg H, Oettel H, Zeller H. Mechanism of the teratogenic effect of tragacanth. Archives of Toxicology 25: 268–295, 1969
Geber WF, Gill TS, Guran MS. Comparative teratogenicity of chlordiazepoxide, diazepam, amitriptyline and imipramine in the fetal hamster. Teratology 21: 39A, 1980
Glade G, Saccar CL, Pereira GR. Cimetidine in pregnancy: apparent transient liver impairment in the newborn. American Journal of Disease in Children 134: 87–88, 1980
Gonjard J, Rumeau-Ronquette C. First-trimester exposure to progestagen-oestrogen and congenital malformations. Lancet 1: 482–483, 1977
Goodman Gilman A, Goodman LS, Rall TW, Murad F. The pharmacological basis of therapeutics, 7th ed., MacMillan Publishing Co, Inc., New York, 1985
Gosselin RE, Smith RP, Hodge HC, Braddock JE. Clinical toxicology of commercial products, 5th ed., Williams and Wilkins, Baltimore, 1984
Gotz H, Reichenberger M. Ergebrisse einer Fragebogenaktion bei 1670 Dermatologen der BD über Nebenwirkungen bei der Griseofulvin-Therapie. Hautarzt 23: 485–492, 1972
Greenberger PA, Patterson R. Management of asthma during pregnancy. New England Journal of Medicine 312: 897, 1985
Hadjigeorgiou E, Kitsiou S, Psarondakis A, Segos C, Nicolopoulos D, et al. Antepartum aminophylline treatment for prevention of the respiratory distress syndrome in premature infants. American Journal of Obstetrics and Gynecology 135: 257–260, 1979
Hague WM. Prescribing in pregnancy: treatment of endocrine diseases. British Medical Journal 294: 297–300, 1987
Haram K, Digranes A. Vulvovaginal candidiasis in pregnancy treated with clotrimazole. Acta Obstetrica et Gynecologica Scandinavica 57: 453–455, 1978
Hart CW, Naunton RF. The ototoxicity of chloroquine phosphate. Archives of Otolaryngology 80: 407–412, 1964
Hasegawa Y, Yoshida T, Kozen T. A teratological study on cefamandole in rats and rabbits. Chemotherapy 27 (Suppl. 5): 658–681, 1979
Hastwell G. Salbutamol aerosol in premature labour. Lancet 2: 1212–1213, 1975
Hayes Jr WJ. Pesticides studied in man, Williams and Wilkins, Baltimore, 1982
Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy, PSG Publishing Company, Inc., Littleton, MA, 1977
Hemminki K, Sorsa M, Vainio H. Occupational hazards and reproduction, Hemisphere Publishing Corporation, Washington, 1985
Holmberg PC. CNS defects in children born to mothers exposed to organic solvents during pregnancy. Lancet 2: 177–179, 1979
Holt D, Webb M. The toxicity and teratogenicity of mercuric mercury in the pregnant rat. Archives of Toxicology 58: 243–248, 1986
Ito C, Shibutani Y, Taya K, Ohnishi H. Toxicological studies of miconazole, 3: teratological studies of miconazole in rabbits. Jyakuhin Kenkyu 7: 377–381, 1976
Jacobson BD. Hazards of norethindrone therapy during pregnancy. American Journal of Obstetrics and Gynecology 84: 962–968, 1962
Jamerot G, Into-Malberg MB, Esbjorner E. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scandinavian Journal of Gastroenterology 16: 693–697, 1981
Janardhan A, Sattur PB, Sisodia P. Teratogenicity of methyl benzimidazole carbamate in rats and rabbits. Bulletin of Environmental Contamination and Toxicology 33: 257–263, 1984
Jindra J, Anjezdska A, Janousek V. Embryotoxic effects of high doses of griseofulvin on the skeleton of the albino mouse. In Evaluation of embryotoxicity, mutagenicity and carcinogenicity risks in new drugs: Proceedings of the 3rd symposium on toxicology testing for safety of new drugs, Prague, 161–165, 1979
Kato T. Embryonic abnormalities of the CNS caused by the fuelgas inhalation of the mother animal. Folia Psychiatrica et Neurologica Japonica 11: 301–324, 1958
Kavlock RJ, Chernoff N, Gray LE, Gray JA, Whitehouse D. Teratogenic effects of benomyl in the Wistar rat and CD-I mouse, with emphasis on the route of administration. Toxicology and Applied Pharmacology 62: 44–54, 1982
Koos BJ, Longo LD. Mercury toxicity in the pregnant woman, fetus and newborn infant. American Journal of Obstetrics and Gynecology 126: 390–409, 1976
Koren G, Bologa-Campeanu M, Long D, Feldman Y, Henderson K, et al. The perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Submitted for publication, 1988
Koren G, Feldman Y, Shear N. Motherisk: a new approach to antenatal counselling of drug/chemical exposure. Veterinary and Human Toxicology 28: 563–565, 1986
Koren G, MacLeod SM. Monitoring and avoiding drug and chemical teratogenicity. Canadian Medical Association Journal 135: 1079–1081, 1986
Lecyk M. Toxicity of copper sulfate in mice embryonic development. Zoologica Poloniae 28: 101–106, 1980
Lederer J. Saccharin, its by-products and their teratogenic effects. Louvain Medicale 96: 495–501, 1977
Letourneau EG. Are video display terminals safe? Canadian Medical Association Journal 125: 533–534, 1981
Levy G, Garretson LK, Soda DM. Evidence of placental transfer of acetaminophen. Pediatrics 55: 895, 1975
Livingstone CS. Neonatal goitre. British Medical Journal 2: 50, 1966
Loevy H, Roth BF. Induced cleft palate development in mice: comparison between the effect of epinephrine and cortisone. Anatomical Record 160: 386, 1968
London JB. Prescribing in pregnancy: psychotropic drugs. British Medical Journal 294: 167–169, 1987
Longo LD. The biological effects of carbon monoxide in the pregnant woman, fetus and newborn infant. American Journal of Obstetrics and Gynecology 129: 69–103, 1977
Mangurten HH, Benawra R. Neonatal codeine withdrawal in infants of non-addicted mothers. Pediatrics 65: 159–160, 1980
Marshall E. FDA sees no radiation risk in VDT screens. Science 212: 1120–1121, 1981
Mau G. Progestins during pregnancy and hypospadias. Teratology 24: 285–287, 1981
McClain RM, Becker BA. Effects of organolead compounds on rat embryonic and fetal development. Toxicology and Applied Pharmacology 21: 265–274, 1972
McColl JD. Dimenhydrinate in pregnancy. Canadian Medical Association Journal 88: 861, 1963
McCormack WM, George H, Donner A, Kodgis LF, Albert S, et al. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrobial Agents and Chemotherapy 12: 630–635, 1977
Mellin GW. Comparative teratology. Anesthesiology 29: 1–4, 1968
Mellin GW, Katzenstein M. Meclozine and fetal abnormalities. Lancet 1: 222–223, 1963
Milkovich L, van den Berg BJ. Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. New England Journal of Medicine 291: 1268–1271, 1979
Mitchell AA, Rosenberg L, Shapiro S, Slone D. Birth defects related to Bendectin use in pregnancy I: oral clefts and cardiac defects. Journal of the American Medical Association 245: 2311–2314, 1981
Miyoshi T. Experimental studies on the effects of toxicants on pregnancy of rats. Journal of Osaka City Medical Centre 8: 309–318, 1959
Morgan J. Metronidazole treatment in pregnancy. International Journal of Gynaecology and Obstetrics 15: 501–502, 1978
Nater JP, DeGroot AC. Unwanted effects of cosmetics and drugs used in dermatology, Elsevier, Amsterdam, 1985
Ochoa AG. Trimethoprim and sulfamethoxazole in pregnancy. Journal of the American Medical Association 217: 1244, 1971
Ottolenghi AD, Haseman JK, Suggs F. Teratogenic effects of aldrin, dieldrin, endrin in hamsters and mice. Teratology 9: 11–16, 1974
Owaki Y, Sakai T, Momiyama H. Teratological studies on pyrantel pamoate in rats and rabbits. Oyo Yakuri 5: 33–50, 1970
Palanker AL, Keating JW, Weinberg MS, Sheffner AL, Dean R. Reproductive teratogenic and egg production studies in animals fed SO2-treated activated sewage sludge. Toxicology and Applied Pharmacology 25: 454, 1973
Peterson WF. Pregnancy following oral contraceptive therapy. Obstetrics and Gynecology 34: 363–367, 1969
Philipson A, Sabath LD, Charles D. Erythromycin and clindamycin absorption and elimination in pregnant women. Clinical Pharmacology and Therapeutics 19: 68–77, 1976
Pope WD, Halsey MJ, Lansdown AB, Bateman PE. Lack of teratogenic dangers with halothane. Acta Anaesthesiologica Belgica 23 (Suppl.): 169–173, 1975
Reid DWJ, Caille G, Kaufmann NR. Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination. Canadian Medical Association Journal 112: 67S–72S, 1975
Robinson DH, Shepherd DA. Control of head lice in school children. Current Therapeutic Research 27: 1–6, 1980
Roe TF, Alfi OS. Ambiguous genitalia in XX male children: report of two infants. Pediatrics 60: 55–59, 1977
Rom WN. Effects of lead on the female and reproduction: a review. Mt. Sinai Journal of Medicine 43(5): 542–551, 1976
Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Lonik C, et al. Lack of relation of oral clefts to diazepam use during pregnancy. New England Journal of Medicine 309: 1282–1285, 1983
Rothman KJ, Fyler DC, Golblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart disease. American Journal of Epidemiology 109: 433–439, 1979
Rothman KJ, Lonik C. Oral contraceptives and birth defects. New England Journal of Medicine 299: 522–524, 1978
Rudolph AM. Effects of aspirin and acetaminophen in pregnancy and in the newborn. Archives of Internal Medicine 141: 358–363, 1981
Rumack CM, Guggenheim MA, Rumack BM, Peterson RG, Johnson ML, et al. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstetrics and Gynecology 58 (Suppl.): 525–565, 1981
Safra JM, Oakley GP. Association between cleft lip with or without cleft palate and neonatal exposure to diazepam. Lancet 2: 478–480, 1975
Sanmiguel GS, Ferrer AP, Alberich MT, Genaoui BM. Consideraciones sobre el tratamiento de la infancia y en el embarazo. Actas Dermo-sifiliograficas 71: 105–108, 1980
Saxen I. Cleft palate and maternal diphenhydramine intake. Lancet 1: 407–408, 1974
Saxen I. Associations between oral clefts and drugs taken during pregnancy. International Journal of Epidemiology 4: 37–44, 1975
Schardein JL. Chemically induced birth defects, Marcel Dekker, Inc., New York, 1985
Schindler AM. Isolated neonatal hypomagnesaemia associated with maternal overuse of stool softeners. Lancet 2: 822, 1984
Sheppard TH. Catalog of teratogenic agents, 5th ed., Johns Hopkins University Press, Baltimore, 1986
Shiono Ph, Mills JL. Oral clefts and diazepam use during pregnancy. New England Journal of Medicine 311: 919–920, 1984
Singh AR, Lawrence WH, Autian J. Teratogenicity of phthalate esters in rats. Journal of Pharmaceutical Sciences 61: 51–55, 1972
Singh N, Donovan CM, Hanshaw JB. Neonatal lead intoxication in a prenatally exposed infant. Journal of Pediatrics 93: 1019–1021, 1978
Stein ZA, Hatch MC. Reproductive problems in the workplace, Vol. 1, No. 3, Hanley and Belfus, Philadelphia, 1986
Stone D, Matalka E, Pulaski B. Do artificial sweeteners ingested in pregnancy affect the offspring? Nature 231: 53, 1971
Strandberg M, Sandback K, Axelson O, Sundell L. Spontaneous abortions among women in hospital laboratory. Lancet 1: 384–385, 1978
Sturtevant FM. Use of aspartame in pregnancy. International Journal of Fertility 30(1): 85–87, 1985
Tamura J, Sato N, Ezaki H. Teratological study on ranitidine hydrochloride in rabbits. Journal of Toxicological Sciences 8 (Suppl. 1): 141–150, 1983
Taylor JM, Friedman L. Combined chronic feeding and threegeneration reproduction study of sodium saccharin in the rat. Toxicology and Applied Pharmacology 29: 154, 1974
Thomas DJB, Dove AF, Alberti KGMM. Metabolic effects of salbutamol infusion during premature labour. British Journal of Obstetrics and Gynaecology 84: 497–499, 1977
Van Leeuwen G, Guthrie R, Stange F. Narcotic withdrawal reaction in a newborn infant due to codeine. Pediatrics 36: 635–636, 1965
Walker BE. Effect of glucocorticoids on palate development in the rat. Anatomical Record 163: 281, 1969
Walker BE. Induction of cleft palate in rats with anti-inflammatory drugs. Teratology 4: 39–42, 1971
Wallenberg HCS, Wladimiroff JW. Recurrence of vulvovaginal candidiosis during pregnancy: comparison of miconazole vs nystatin treatment. Obstetrics and Gynecology 48: 491–494, 1976
Wasz-Hockert O, Nummi S, Vuopala S, Jarvinen P. Transplacental passage of azidocillin, ampicillin and penicillin G during early and late pregnancy. Acta Paediatrica Scandinavica 206 (Suppl.): 109–110, 1970
Wilk AL. Relation between teratogenic activity and cartilage-binding affinity of norchlorcyclizine analogues. Teratology 2: 272, 1969
Wilson JG, Brent RL. Are female sex hormones teratogenic? American Journal of Obstetrics and Gynecology 141: 567–580, 1981
Windholz M (Ed.) The Merck index, 9th ed., Merck and Co., Inc. Rahway, 1976
Wolfe MS, Cordero JF. Safety of chloroquine in chemosuppression of malaria during pregnancy. British Medical Journal 290: 1466–1467, 1985
Wolff F, Berg R, Bolte A. Clinical study of the labor inhibiting effects and side effects of ASA. Geburtshilfe Frauenheilkd 41: 96–100, 1981
Wong O, Utidjian MD, Karten VS. Retrospective evaluation of reproductive performance of workers exposed to ethylene dibromide (EDB). Journal of Occupational Medicine 21: 98–102, 1979
Zhivkov E, Atanasov L. Experiments in obtaining and preventing congenital cataracts in rats. Opthalmologia 2: 105–112, 1965
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bologa-Campeanu, M., Koren, G., Rieder, M. et al. Prenatal Adverse Effects of Various Drugs and Chemicals. Dis-Manage-Health-Outcomes 3, 307–323 (1988). https://doi.org/10.1007/BF03259942
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259942